Determinants of Post-COVID-19 Conditions among SARS-CoV-2-Infected Patients in Saudi Arabia: A Web-Based Cross-Sectional Study

👤 Abdallah Yousef Naser | b01575
🎓 Pharmacy

📅 2022-08-23

A nationwide survey of public COPD knowledge and awareness in Saudi Arabia: A population-based survey of 15,000 adults

👤 Abdallah Yousef Naser | B01575
🎓 Pharmacy

📅 2023-07-05

Knowledge of and Attitude towards Epilepsy among the Jordanian Community

👤 Abdallah Yousef Naser | b01575
🎓 Pharmacy

📅 2022-08-18

Attitudes and Practices of the Public Toward Precautionary Measures Post-COVID-19 Pandemic in Saudi Arabia

👤 Abdallah Yousef Naser | B01575
🎓 Pharmacy

📅 2023-07-15

An Ecological Analysis of Hospitalization Patterns for Diseases of the Nervous System in England and Wales over the Last 20 Years

👤 Abdallah Yousef Naser | b01575
🎓 Pharmacy

📅 2022-09-01

Prevalence of Nomophobia and Its Association with Academic Performance Among Physiotherapy Students in Saudi Arabia: A Cross- Sectional Survey

👤 Abdallah Yousef Naser | B01575
🎓 Pharmacy

📅 2023-07-25

Perspectives, practices, and challenges of online teaching during COVID-19 pandemic: A multinational survey

👤 Abdallah Yousef Naser | B01575
🎓 Pharmacy

📅 2023-08-11

Impact of Isoniazid and Rifampicin on Chemokines with Clinical Parameters in Tuberculosis Patients

👤 Samer Hasan Hussein Alali | B01373
🎓 Pharmacy

📅 2023-02-20

Hospitalisations related to nervous-system diseases in Australia, 1998–2019: a secular trend analysis

👤 Abdallah Yousef Naser | B01575
🎓 Pharmacy

📅 2023-09-27

Blood Group and Response to Bariatric Surgery in Morbidly Obese Patients: A Retrospective Study in Saudi Arabia

👤 Abdallah Yousef Naser | b01575
🎓 Pharmacy

📅 2023-01-01

Hospitalisation Trends for Choroid and Retina Diseases in the Past 20 Years: An Ecological Study in Australia.

👤 Abdallah Yousef Naser | B01575
🎓 Pharmacy

📅 2023-10-17

In Vitro Anticancer Properties of Novel Bis-Triazoles

👤 Abdallah Yousef Naser | b01575
🎓 Pharmacy

📅 2023-01-01

📝 Here, we describe the anticancer activity of our novel bis-triazoles MS47 and MS49, developed previo...